About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulato
| Publication Type | Academic Article |
| Authors | Crystal R, Jaffe A, Brody S, Mastrangeli A, McElvaney N, Rosenfeld M, Chu C, Danel C, Hay J, Eissa T |
| Journal | Hum Gene Ther |
| Volume | 6 |
| Issue | 5 |
| Pagination | 643-66 |
| Date Published | 05/01/1995 |
| ISSN | 1043-0342 |
| Keywords | Adenoviridae, Clinical Trials, Phase I as Topic, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Transfer Techniques, Genetic Therapy |
| DOI | 10.1089/hum.1995.6.5-643 |
| PubMed ID | 7578401 |